Professor Suresh Mahalingam from Griffith's Institute for Biomedicine and Glycomics has been working on this research for the past four years. This is a live attenuated intranasal vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback